Finance

Lists
3371:FRA
Corbus Pharmaceuticals Holdings Inc
€9.22
-0.22%
(-0.020) 1D
Sep 8, 8:03:52 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 3371...
Open
€9.22
High
€9.22
Low
€9.22
Mkt. cap
205.40M
Avg. vol.
198.00
Volume
0.00
52-wk high
€18.40
52-wk low
€5.80
No. of employees
36
Open
€9.22
High
€9.22
Low
€9.22
Mkt. cap
205.40M
Avg. vol.
198.00
Volume
0.00
52-wk high
€18.40
52-wk low
€5.80
No. of employees
36
About Corbus Pharmaceuticals Holdings Inc
CEO-
Employees36
FoundedJan 1, 2009
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
20.86M
18.41M
19.82M
31.18M
Cost of revenue
20.86M
18.41M
19.82M
31.18M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.56M
3.56M
4.48M
5.02M
Operating expense
3.56M
3.56M
4.48M
5.02M
Total operating expenses
24.42M
21.97M
24.30M
36.19M
Operating income
-24.42M
-21.97M
-24.30M
-36.19M
Other non operating income
-50.00K
-1.10M
-67.00K
-11.00K
EBT including unusual items
-23.34M
-20.56M
-22.97M
-35.04M
EBT excluding unusual items
-23.34M
-21.66M
-22.97M
-35.04M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-23.34M
-20.56M
-22.97M
-35.04M
Net profit margin
-
-
-
-
Earnings per share
-1.90
-1.25
-1.23
-1.81
Interest and investment income
1.12M
1.41M
1.40M
1.16M
Interest expense
-
-
-
-
Net interest expenses
1.12M
1.41M
1.40M
1.16M
Depreciation and amortization charges
-
-
-
-
EBITDA
-24.37M
-21.92M
-24.26M
-36.14M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps